{"filings":[{"id":2191037,"accession_number":"0001156375-26-000051","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2026-08-11T20:44:37+00:00","items":["7.01","9.01"],"status":"ready","headline":"CME Group announces pricing changes via Special Executive Report No. 9799","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Pricing changes communicated to clients on Aug 11, 2026 via Special Executive Report No. 9799.","Full details posted on CME Group's website; 8-K provides no fee figures or scope.","No other financial impact or guidance provided in the filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":1784676,"accession_number":"0001156375-26-000042","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2026-07-22T11:15:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"CME Group reports Q2 2026 results; press release not provided in filing text","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["Filing states a press release was attached as Exhibit 99.1 reporting financial results for quarter ended June 30, 2026.","No specific financial figures (revenue, EPS, volumes) are available in the 8-K body or appended exhibit text.","Non-GAAP measures are included in the press release per management's disclosure, but details are absent from this filing.","Investors should refer to the full press release for actual results and guidance."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":1093798,"accession_number":"0001193125-26-273442","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2026-06-17T12:35:53+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"CME Group CEO Terry Duffy to transition to Executive Chairman in March 2027; President & CFO Lynne Fitzpatrick named CEO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Terrence A. Duffy will become Executive Chairman effective March 1, 2027 (or later when 2026 10-K is filed); he remains CEO until then.","Lynne C. Fitzpatrick, currently President and CFO, will succeed Duffy as CEO and join the Board on the transition date.","Fitzpatrick's CEO compensation: $1.2M base salary; annual bonus target 200% of base; LTI target 700% of base.","Company will conduct a search for a successor to Fitzpatrick as CFO.","Duffy's transition agreement provides continued base salary, bonus and equity vesting at target through his Executive Chairman term ending Dec 31, 2027."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":974476,"accession_number":"0001156375-26-000035","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2026-06-10T20:50:48+00:00","items":["5.07"],"status":"ready","headline":"CME Group shareholder proposals to eliminate Class B director election rights fail; Class B-3 director remains holdover","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Item 4 to eliminate Class B-1 right to elect three directors failed (27.84% B-1 FOR; 80.27% combined FOR but needed majority of outstanding B-1).","Item 5 to eliminate Class B-2 right to elect two directors failed (23.37% B-2 FOR; 80.27% combined FOR).","Item 6 to eliminate Class B-3 director election lacked quorum (28.44% of B-3 present).","Item 7 (certificate amendment contingent on Items 4-6) passed but will not be filed due to those failures.","Class B-1 and B-2 directors re-elected; Class B-3 director Elizabeth A. Cook continues as holdover."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.15,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":527316,"accession_number":"0001156375-26-000028","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2026-05-19T20:21:13+00:00","items":["5.07"],"status":"ready","headline":"CME Group adjourns four proposals due to Class B quorum shortfall; elects all director nominees","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Class B-1 through B-4 failed quorum (33.3% required); only 24-33% present. Proposals 4-8 adjourned to June 9, 2026 virtual meeting.","14 equity directors elected; Terrence A. Duffy received 267.9M for, 26.6M against, 459.9K abstain.","Ratification of Ernst & Young as auditor approved: 291.4M for, 26.6M against, 494.6K abstain.","Advisory say-on-pay approved: 259.6M for, 34.5M against, 854.3K abstain; 23.5M broker non-votes.","Total shares outstanding 362.8M; overall quorum 87.78% due to Class A presence."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.15,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":91574,"accession_number":"0001156375-26-000022","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2026-04-27T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"CME Group subsidiary amends $7B clearing house credit facility","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Amendment No. 11 to 364-day multi-currency revolving secured credit facility, dated April 22, 2026.","Facility size remains $7B with accordion feature to increase to $10B.","Proceeds used for temporary liquidity in clearing firm default, depositary default, or payment system disruption.","Collateral includes cash, U.S. Treasury securities, and performance bond assets.","Facility requires CME to maintain a consolidated tangible net worth test."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":91573,"accession_number":"0001156375-26-000016","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2026-04-22T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"CME Group files 8-K for Q1 2026 earnings; press release exhibit not provided in input","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["Furnished quarterly financial results for quarter ended March 31, 2026.","Exhibit 99.1 press release text is missing; specific figures are unavailable.","No guidance, segment data, or non-GAAP adjustments can be extracted.","Investors should refer to the full press release on the company's website."],"consensus_eps_estimate":null,"consensus_eps_actual":3.18,"consensus_revenue_estimate":null,"consensus_revenue_actual":1880100000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101768,"accession_number":"0001156375-26-000006","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2026-02-04T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"CME Group reports Q4 2025 adjusted EPS $2.68, revenue $1.8B; 2026 dividend raised 10% to $1.30/quarter","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 2025 revenue $1.8B (+20% YoY), record full-year revenue $7.1B (+35%).","Q4 adjusted EPS $2.68 (+29% YoY); full-year adjusted EPS $10.67.","Record Q4 average daily volume 28.4M contracts (+36%); full-year ADV 27.8M (+31%).","Board authorizes 10% dividend increase to $1.30/quarter beginning Q1 2026.","Adjusted operating expenses Q4 $712M (+20%), driven by higher compensation and tech."],"consensus_eps_estimate":null,"consensus_eps_actual":11.16,"consensus_revenue_estimate":null,"consensus_revenue_actual":6520600000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":101767,"accession_number":"0001156375-26-000002","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2026-02-02T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"CME Group Announces Pricing Changes via Special Executive Report 9676","summary_kind":"llm","event_type":"other_material","confidence":"medium","bullets":["On February 2, 2026, CME Group communicated pricing changes to clients in Special Executive Report 9676.","The pricing change notice was posted to CME Group's website under Regulation FD disclosure.","The disclosure was reported via Form 8-K items 7.01 and 9.01 on February 2, 2026.","CME Group Inc. (ticker: CME) is the registrant and exchange operator."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":118086,"accession_number":"0001156375-25-000204","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2025-10-22T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"CME Group Q3 2025 earnings reported; press release not provided","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["Exhibit 99.1 press release text missing; specific financial figures unavailable.","Press release dated October 22, 2025, covers quarter ended September 30, 2025.","Non-GAAP financial measures included; reconciliation provided in release."],"consensus_eps_estimate":null,"consensus_eps_actual":7.92,"consensus_revenue_estimate":null,"consensus_revenue_actual":4871900000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":134532,"accession_number":"0001156375-25-000190","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2025-09-11T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"CME Group CAO Jack Tobin to retire; will stay through Oct 30, 2026","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Jack Tobin, Managing Director and Chief Accounting Officer, notified retirement on Sept 9, 2025.","He will remain CAO until Oct 30, 2026, to support transition.","Tobin served as CAO since 2015 and has been with CME for over 23 years.","Retirement is voluntary, not due to any disagreements over accounting or policies.","Company will initiate search for successor; Tobin to assist with transition."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":134531,"accession_number":"0001156375-25-000184","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2025-07-25T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"CME Group wins unanimous jury verdict in Class B shareholder lawsuit","summary_kind":"llm","event_type":"litigation","confidence":"high","bullets":["Jury returned unanimous verdict on July 25, 2025 in favor of CME Group and CBOT.","Lawsuit filed January 15, 2014 by certain Class B shareholders alleging breach of contract and implied covenant.","Case was in Circuit Court of Cook County, Chancery Division; putative class action dismissed.","Verdict covers alleged violations of core rights in Certificates of Incorporation."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":134530,"accession_number":"0001156375-25-000176","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2025-07-23T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"CME Group Inc. reports financial results for quarter ended June 30, 2025","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["CME Group issued a press release on July 23, 2025 reporting its financial results for the quarter ended June 30, 2025.","The press release includes non-GAAP net income and earnings per share as supplemental financial measures.","Management states that non-GAAP measures provide important supplemental information for comparability with prior reports.","A reconciliation of non-GAAP to GAAP measures is included in the press release."],"consensus_eps_estimate":null,"consensus_eps_actual":5.43,"consensus_revenue_estimate":null,"consensus_revenue_actual":3334300000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":151378,"accession_number":"0001156375-25-000120","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2025-05-09T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"CME Group 2025 annual meeting elects 14 directors, ratifies auditor, approves say-on-pay","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All 14 equity directors elected; highest votes for Benesh (280.3M) and Lucas (280.1M); lowest for Lockett (170.0M).","Ratification of Ernst & Young as independent auditor approved: 289.99M for, 21.30M against.","Advisory vote on named executive officer compensation passed: 251.22M for, 36.03M against.","Class B-1, B-2, B-3 director elections lacked quorum; holdover directors continue; one B-2 seat vacant."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":151377,"accession_number":"0001156375-25-000098","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2025-04-25T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"CME Group enters $2.25B credit facility maturing 2030, amends $7B clearing facility","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["New $2.25B multi-currency revolving credit facility matures April 23, 2030; can be increased to $3.25B.","Facility replaces 2021 credit agreement; proceeds for working capital and general corporate purposes.","CME subsidiary amended its $7B 364-day secured credit facility (expandable to $10B) for clearing house liquidity.","Senior Credit Facility requires minimum consolidated net worth and customary covenants."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":151376,"accession_number":"0001156375-25-000093","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2025-04-23T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"CME Group Q1 2025 earnings released; specifics not included in 8-K","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["CME Group disclosed Q1 2025 financial results via press release on April 23, 2025, but no revenue or EPS figures are available in this filing.","The press release includes both GAAP and non-GAAP measures to supplement financial statements.","Management believes non-GAAP net income and EPS provide better comparability with prior reports."],"consensus_eps_estimate":null,"consensus_eps_actual":2.62,"consensus_revenue_estimate":null,"consensus_revenue_actual":1642300000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":151375,"accession_number":"0001193125-25-079725","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2025-04-14T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"CME Group and S&P Global sell OSTTRA joint venture to KKR for $3.1B","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Total enterprise value of $3.1 billion; proceeds split 50/50 between CME and S&P Global.","Transaction expected to close in second half of 2025, subject to regulatory approvals.","OSTTRA co-CEOs Guy Rowcliffe and John Stewart to remain in their current roles.","KKR to support OSTTRA with increased technology investments and an employee equity program.","OSTTRA, established in 2021, provides post-trade solutions for OTC markets including interest rates, FX, credit, and equities."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":170270,"accession_number":"0001193125-25-050881","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2025-03-10T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"CME Group issues $750M 4.400% Notes due 2030 to refinance 2025 notes","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued $750M aggregate principal of 4.400% Notes due March 15, 2030 at 99.573% of par.","Interest payable semi-annually on March 15 and September 15, starting September 15, 2025.","Net proceeds, with cash on hand, will redeem all $750M of outstanding 3.00% notes due 2025.","Notes issued under existing indenture with U.S. Bank National Association as trustee."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":170269,"accession_number":"0001193125-25-045633","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2025-03-04T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"CME Group issues $750M of 4.400% Notes due 2030 in public offering","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Principal amount $750M at 4.400% interest, maturing 2030.","Underwriters include Barclays, J.P. Morgan, and Wells Fargo.","Underwriting agreement includes customary representations, warranties, and indemnification.","Proceeds intended for general corporate purposes (not explicitly stated in filing)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":170268,"accession_number":"0001156375-25-000007","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2025-02-12T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"CME Group reports Q4 2024 financial results; details not available in filing text","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["Press release for quarter ended December 31, 2024 furnished as Exhibit 99.1.","Specific financial metrics (revenue, EPS, volumes) not provided in the 8-K body.","Non-GAAP measures included in the press release per Regulation G reconciliation.","Investor should refer to the full press release for performance data."],"consensus_eps_estimate":null,"consensus_eps_actual":9.67,"consensus_revenue_estimate":null,"consensus_revenue_actual":6130100000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":187281,"accession_number":"0001193125-24-274928","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2024-12-11T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"CME Group updates Clearing House collateral fees and client pricing","summary_kind":"llm","event_type":"other","confidence":"low","bullets":["Changes communicated via Advisory Notice 24-383 and Special Executive Report 9482.","Copies of both notices posted to CME Group's website for review.","Effective date of changes not specified in the filing; details available online."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":187280,"accession_number":"0001193125-24-271111","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2024-12-05T23:59:59+00:00","items":["7.01","8.01","9.01"],"status":"ready","headline":"CME Group declares $2.1B annual variable dividend ($5.80/share) and $3B share repurchase program","summary_kind":"llm","event_type":"dividend","confidence":"high","bullets":["Annual variable dividend of $5.80 per share ($2.1B total) payable Jan 16, 2025 to holders of record Dec 27, 2024.","Board authorized $3B share repurchase program with no expiration date, subject to market conditions.","Total dividend yield for 2024 is 4.9%, an 8% increase from dividends declared in 2023.","Beginning in 2026, annual variable dividend will align with Q1 regular dividend paid in March rather than at year-end.","Company has paid over $28B in quarterly and variable dividends since adopting the structure in 2012."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":187279,"accession_number":"0001193125-24-252912","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2024-11-07T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"CME Group extends CEO Terry Duffy's contract to Dec 2026; appoints new President/CFO and COO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Chairman and CEO Terry Duffy's employment extended through December 31, 2026; no changes to base salary, bonus, or LTI target.","CFO Lynne Fitzpatrick promoted to President and CFO; she has been CFO since April 2023.","COO Julie Holzrichter steps down; will remain as advisor. Suzanne Sprague appointed COO and Global Head of Clearing.","Duffy's unvested time-vesting equity awards to vest upon term expiration; performance awards vest based on actual results."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":187278,"accession_number":"0001156375-24-000187","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2024-10-23T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"CME Group reports Q3 results; press release not fully extracted","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["Filing indicates Q3 2024 earnings released; press release text not included in this excerpt.","Management uses non-GAAP net income and EPS as supplemental measures.","No specific revenue, EPS, or guidance numbers available in the provided text."],"consensus_eps_estimate":null,"consensus_eps_actual":7.27,"consensus_revenue_estimate":null,"consensus_revenue_actual":4604800000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":203784,"accession_number":"0001156375-24-000143","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2024-07-24T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"CME Group announces Q2 2024 earnings; specific figures not provided in filing text","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["Filed Form 8-K on July 24, 2024 with Item 2.02 for Q2 2024 results.","Press release attached as Exhibit 99.1; actual financial data not included in provided text.","No specific EPS, revenue, or segment details available in the filing excerpt."],"consensus_eps_estimate":null,"consensus_eps_actual":4.77,"consensus_revenue_estimate":null,"consensus_revenue_actual":3020400000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":203783,"accession_number":"0001193125-24-175987","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2024-07-08T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"CME Group appoints Mike Dennis as Global Head of Fixed Income effective Aug 5; Dennis resigns from Board","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Mike Dennis joins as Senior Managing Director, Global Head of Fixed Income, reporting to CEO Terry Duffy.","Dennis resigns from CME Board effective July 8; no disagreement with company or board.","Interest rates business grew 14% in Q2 2024, per CEO Terry Duffy.","Tim McCourt named Global Head, Equities, FX, and Alternative Products, reporting to Duffy.","Dennis previously Chief Commercial Officer at ABN AMRO Clearing USA, with 22 years of experience."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":220366,"accession_number":"0001193125-24-136767","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2024-05-13T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"CME Group annual meeting: all equity directors elected, Class B quorum not met","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["All 17 Equity Directors elected; Phyllis Lockett received 103.8M against, highest dissent.","Ratification of Ernst & Young as auditor approved with 289.8M votes for.","Say-on-pay advisory vote passed with 253.1M for and 37.3M against.","Class B-1, B-2, B-3 director elections failed to achieve quorum; incumbents hold over until 2025.","Total shares present 314.5M of 360.0M outstanding (87.3%)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.15,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":220365,"accession_number":"0001193125-24-113786","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2024-04-25T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"CME subsidiary amends credit facility to $7B, eligible to increase to $10B","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Amendment No. 8 to existing 364-day multi-currency credit facility executed on April 24, 2024.","Facility size: $7 billion, eligible to increase to $10 billion.","Purpose: provide temporary liquidity in event of clearing member default, liquidity constraint, depositary default, or delay in payment systems.","Collateral includes clearing firm guaranty fund contributions and performance bond assets.","Parties: CME (borrower), Bank of America (admin agent), Citibank (collateral agent), and other banks."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":220364,"accession_number":"0001156375-24-000070","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2024-04-24T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"CME Group reports Q1 2024 results; specific numbers unavailable from filing text","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["CME Group filed Q1 2024 earnings results on April 24, 2024 via Form 8-K.","The accompanying press release (Exhibit 99.1) was not included in the provided text.","No specific revenue, EPS, or segment data can be extracted."],"consensus_eps_estimate":null,"consensus_eps_actual":2.35,"consensus_revenue_estimate":null,"consensus_revenue_actual":1487900000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":240015,"accession_number":"0001193125-24-062191","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2024-03-07T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"CME Group amends omnibus stock plan to add double-trigger change-of-control vesting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Compensation Committee approved Fourth Amended and Restated Omnibus Stock Plan effective March 1, 2024.","Plan adopts double-trigger vesting: acceleration only if no qualifying replacement awards or involuntary termination within 24 months post-change of control.","Replaces prior Third Amended and Restated Omnibus Stock Plan filed with annual report on February 28, 2024.","Total shares available for awards: 40,229,875; per-person annual limit: 1,250,000 shares; ISO limit: 1,000,000 shares."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":240014,"accession_number":"0001156375-24-000007","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2024-02-14T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"CME Group files Q4 2023 earnings press release; no specific results in this excerpt","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["Press release dated Feb 14, 2024 reports financial results for quarter ended Dec 31, 2023.","Non-GAAP net income and EPS are included as supplemental measures.","Complete financial details are only available in the attached Exhibit 99.1 not provided here."],"consensus_eps_estimate":null,"consensus_eps_actual":8.86,"consensus_revenue_estimate":null,"consensus_revenue_actual":5578900000.0,"consensus_period":"2023-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":257529,"accession_number":"0001193125-23-290001","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2023-12-06T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"CME Group extends CEO Terrence Duffy's contract to Dec 31, 2025 with same terms","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CEO Duffy's term extended to Dec 31, 2025; base salary unchanged at $2M, bonus target 200% of base, equity target 600% of base.","If employed on Dec 31, 2025, unvested time-vesting equity awards vest; performance awards vest based on actual performance over full term.","Similar accelerated vesting and bonus provisions apply if employed on Dec 31, 2023 and Dec 31, 2024.","Board cites Duffy's strategic direction and industry knowledge as key reasons for extension."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":257528,"accession_number":"0001193125-23-284801","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2023-11-29T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"CME Group communicates pricing changes in SER 9295, effective Feb 1, 2024","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["CME Group issued Special Executive Report 9295 on Nov 29, 2023, detailing pricing changes to clients.","The pricing changes take effect on February 1, 2024.","No specific pricing details provided in the filing; full report is posted on the company's website."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":257527,"accession_number":"0001193125-23-275501","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2023-11-13T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"CME Group enters retirement agreement with former CFO Pietrowicz, effective Dec 31, 2023","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["John Pietrowicz to retire as Special Advisor on Dec 31, 2023; will receive base salary through date.","Outstanding time-vesting restricted stock awards to accelerate vest; 50% of performance shares eligible to vest.","Eligibility for 2023 annual bonus; all benefits contingent on release of claims.","Compensation Committee amended annual incentive plan to comply with SEC Rule 10D-1 and NASDAQ listing standards."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":257526,"accession_number":"0001156375-23-000174","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2023-10-25T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"CME Group Q3 2023 earnings released; data missing from filed exhibit","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["Exhibit 99.1 press release dated Oct 25, 2023, is referenced but not included in the provided text.","No specific revenue, EPS, or volume figures are available to summarize.","Analysts should refer to the full press release for actual financial results."],"consensus_eps_estimate":null,"consensus_eps_actual":6.62,"consensus_revenue_estimate":null,"consensus_revenue_actual":4139600000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":274871,"accession_number":"0001193125-23-239199","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2023-09-21T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"CME Clearing House updates collateral fee schedule effective Jan 2, 2024","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Changes to collateral fee schedule communicated via Advisory Notice 23-290 to Clearing Member Firms.","Fee changes effective January 2, 2024; notice posted on company website.","No specific fee amounts or percentage changes disclosed in the filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":274870,"accession_number":"0001156375-23-000121","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2023-07-26T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"CME Group releases Q2 2023 earnings press release; no financial figures provided in 8-K excerpt.","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["CME Group filed an 8-K on July 26, 2023, attaching a press release with Q2 2023 financial results.","The filing text does not include the actual press release content; only the cover page and signature block are present.","Non-GAAP metrics such as adjusted net income and EPS are referenced but not quantified in the excerpt.","Investors should refer to the full press release for revenue, EPS, and segment data."],"consensus_eps_estimate":null,"consensus_eps_actual":4.56,"consensus_revenue_estimate":null,"consensus_revenue_actual":2801800000.0,"consensus_period":"2023-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":292226,"accession_number":"0001193125-23-139299","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2023-05-09T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"CME shareholders reject executive compensation in say-on-pay vote at 2023 annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Advisory vote on executive compensation failed: 192,824,961 against vs 91,525,185 for.","All 17 equity directors elected; Terrence A. Duffy received 257,479,451 votes for.","Ratification of Ernst & Young as independent auditor for 2023 passed with 288,023,555 votes for.","Advisory vote on frequency of future say-on-pay: 1 year approved with 280,593,543 votes.","Class B-1, B-2, B-3 director elections lacked quorum; incumbent directors continue as holdovers."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.15,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":292225,"accession_number":"0001193125-23-123953","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2023-04-28T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"CME Group renews $7B backstop credit facility for clearing subsidiary","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Amendments to 364-day multi-currency secured credit facility for Chicago Mercantile Exchange Inc.","Facility size: $7 billion, eligible to increase to $10 billion.","Purpose: provide temporary liquidity for clearing member default, liquidity constraint, or depositary default.","Collateral includes clearing firm guaranty fund contributions and performance bond assets."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":292224,"accession_number":"0001156375-23-000062","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2023-04-26T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"CME Group reports Q1 2023 results on April 26, 2023; details not available in filing excerpt","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["Press release furnished as Exhibit 99.1 but not included in the provided text.","No specific financial figures (revenue, EPS, volumes) can be extracted from the filing body.","Event type is earnings; confidence is low due to missing exhibit content."],"consensus_eps_estimate":null,"consensus_eps_actual":2.43,"consensus_revenue_estimate":null,"consensus_revenue_actual":1441600000.0,"consensus_period":"2023-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":312940,"accession_number":"0001193125-23-085533","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2023-03-30T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"CME Group appoints Tim McCourt as Global Head of Financial & OTC Products; Sean Tully to retire June 2, 2023","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Sean Tully, Senior Managing Director Global Head Rates & OTC Products, will retire on June 2, 2023.","Tim McCourt appointed to expanded role as Senior Managing Director, Global Head of Financial & OTC Products.","McCourt previously Global Head of Equity & FX Products; will oversee interest rates, equity index, FX, crypto, BrokerTec, EBS.","Retirement agreement provides for vesting of equity awards and healthcare coverage subject to release of claims."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":312939,"accession_number":"0001193125-23-067672","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2023-03-10T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"CME Group finalizes CFO retirement, new severance plan for U.S. employees","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["John W. Pietrowicz to retire as CFO effective 4/1/23; stays as Special Advisor through 12/31/23 with $600K base salary, 100% bonus target, 300% equity target.","New severance plan replaces prior plans; provides 2 weeks pay per year of service, min 4 weeks, max 38 (performance) or 52 (position elimination) weeks.","Severance eligibility requires release of claims; bonus in lieu available for non-performance RIF terminations after 6 months of work.","Plan effective 3/7/23 and covers U.S. employees of Chicago Mercantile Exchange, NYMEX, and NEX Services North America LLC.","Compensation Committee of Board serves as Plan Administrator with full discretionary authority over eligibility and benefits."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":312938,"accession_number":"0001193125-23-054102","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2023-02-28T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"CME Group CFO John Pietrowicz to retire April 1; Lynne Fitzpatrick named successor","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["John W. Pietrowicz retires as CFO effective April 1, 2023; will serve as Special Advisor until Dec 31, 2023.","Lynne Fitzpatrick (44) appointed CFO effective April 1, 2023; previously Deputy CFO since Feb 2022.","Fitzpatrick joined CME in 2006, led corporate development, M&A, and treasury as Managing Director.","No family relationships or material transactions between Fitzpatrick and company executives or directors."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":312937,"accession_number":"0001156375-23-000015","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2023-02-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"CME Group announces Q4 2022 results; specific figures not available in filing","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["Press release attached reporting financial results for quarter ended Dec 31, 2022.","Non-GAAP net income and EPS included as supplemental measures with reconciliation.","No specific revenue, EPS, or YoY comparisons provided in the filing text.","CFO John W. Pietrowicz signed the Form 8-K on February 8, 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":7.4,"consensus_revenue_estimate":null,"consensus_revenue_actual":5019400000.0,"consensus_period":"2022-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":331462,"accession_number":"0001193125-22-301477","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2022-12-09T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"CME Group amends bylaws for Universal Proxy Rules compliance, removes Class B Nominating Committee references","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board approved and adopted Amended Bylaws effective Dec 7, 2022, addressing Universal Proxy Rule 14a-19.","Requires evidence of shareholder compliance with Universal Proxy solicitation requirements.","Company provided a remedy if a shareholder fails to satisfy Universal Proxy Rules.","Removed references to Class B Nominating Committees, which concluded as of 2020 Annual Meeting.","Also includes non-substantive and clarifying changes to Bylaws."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":331461,"accession_number":"0001193125-22-293960","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2022-11-29T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"CME Group announces pricing changes effective February 1, 2023 via SER 9098","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Pricing changes communicated to clients on November 29, 2022 via Special Executive Report 9098.","Changes effective February 1, 2023; details posted to company website.","No further specifics on magnitude or scope of pricing adjustments provided in filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":331460,"accession_number":"0001156375-22-000306","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2022-10-26T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"CME Group reports Q3 2022 financial results; press release attached","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["Press release as Exhibit 99.1 covers Q3 2022 results for the period ended September 30, 2022.","Release includes non-GAAP net income and EPS with reconciliation to GAAP.","Specific financial figures (revenue, EPS, segment data) not included in this 8-K excerpt."],"consensus_eps_estimate":null,"consensus_eps_actual":5.64,"consensus_revenue_estimate":null,"consensus_revenue_actual":3811600000.0,"consensus_period":"2022-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":348987,"accession_number":"0001156375-22-000211","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2022-07-27T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"CME Group reports Q2 2022 results; press release text not available for extraction","summary_kind":"llm","event_type":"earnings","confidence":"low","bullets":["Filing under Item 2.02 indicates financial results for quarter ended June 30, 2022 were released.","Exhibit 99.1 press release dated July 27, 2022 is referenced but the full text was not provided in this summary.","No specific EPS, revenue, or other financial figures can be confirmed from the available information."],"consensus_eps_estimate":null,"consensus_eps_actual":3.78,"consensus_revenue_estimate":null,"consensus_revenue_actual":2583800000.0,"consensus_period":"2022-Q2","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":365808,"accession_number":"0001193125-22-143625","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2022-05-06T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"CME Group say-on-pay fails; all equity directors re-elected at 2022 annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Shareholders rejected advisory vote on executive compensation: 211M against vs 64M for (76.7% against).","All 17 Equity Directors re-elected to 2023; Terrence Duffy received 89% of votes cast.","Ratification of Ernst & Young as auditor passed with 288M votes for, 9.6M against.","Omnibus Stock Plan, Director Stock Plan, and Employee Stock Purchase Plan all approved.","Class B-1 and B-3 director elections lacked quorum; incumbents continue as holdovers."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.15,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":365807,"accession_number":"0001193125-22-127526","cik":1156375,"company_name":"CME GROUP INC.","ticker":"CME","form_type":"8-K","filed_at":"2022-04-28T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"CME subsidiary amends $7B multi-currency credit facility; can be upsized to $10B","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Chicago Mercantile Exchange entered Amendment No. 6 to its 364-day secured revolving credit facility.","Facility size is $7 billion, eligible for increase to $10 billion.","Provides temporary liquidity for clearing member defaults, depositary defaults, or payment system delays.","Collateral includes clearing member guaranty fund contributions and performance bond assets.","New banks joined; existing banks and terms continued under amended agreement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":101018547291.16359,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":"2022-04-28T23:59:59+00:00|365807"}